Pneumococcal vaccination and pneumonia: Even a low level of clinical effectiveness is highly cost-effective

Authors
Ament, A Fedson, DS Christie, P
Citation
A. Ament et al., Pneumococcal vaccination and pneumonia: Even a low level of clinical effectiveness is highly cost-effective, CLIN INF D, 33(12), 2001, pp. 2078-2079
Citations number
5
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
CLINICAL INFECTIOUS DISEASES
ISSN journal
10584838 → ACNP
Volume
33
Issue
12
Year of publication
2001
Pages
2078 - 2079
Database
ISI
SICI code
1058-4838(200112)33:12<2078:PVAPEA>2.0.ZU;2-G
Abstract
Most studies of the cost-effectiveness of pneumococcal vaccination show ver y favorable cost-effectiveness ratios for preventing pneumococcal pneumonia , but they make the controversial assumption that vaccination is equally ef fective in preventing bacteremic (BPP) and nonbacteremic (NBPP) pneumonia. However, the results of our study showed that, compared with preventing BPP alone, the cost-effectiveness of pneumococcal vaccination increased substa ntially even when only a small proportion of additional cases of NBPP were prevented.